2014
DOI: 10.15412/j.jbtw.01030601
|View full text |Cite
|
Sign up to set email alerts
|

Exploring vivo toxicity assessment of copper oxide nanoparticle in Wistar rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
13
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(17 citation statements)
references
References 17 publications
3
13
1
Order By: Relevance
“…Interestingly, reducing the dosage of dietary copper (both CuS and CuNP) increased the activity of plasma AST, ALT and ALP. Given the opposite data presented by numerous authors [ 29 , 44 , 45 ] the results of our study were surprising and difficult to interpret, especially as the values of some of the parameters in the CuD (Cu-deficient) group were similar to those obtained in the high-dosage treatment while the values of others were similar to those noted in the low-dosage treatment. Similarly, Shukla et al [ 46 ], administering 1 mg Cu/kg BW in the form of CuSO 4 to Wistar rats orally for 16 weeks observed a significant decrease in ALT activity in both the blood and the liver, but no effect was on AST activity.…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…Interestingly, reducing the dosage of dietary copper (both CuS and CuNP) increased the activity of plasma AST, ALT and ALP. Given the opposite data presented by numerous authors [ 29 , 44 , 45 ] the results of our study were surprising and difficult to interpret, especially as the values of some of the parameters in the CuD (Cu-deficient) group were similar to those obtained in the high-dosage treatment while the values of others were similar to those noted in the low-dosage treatment. Similarly, Shukla et al [ 46 ], administering 1 mg Cu/kg BW in the form of CuSO 4 to Wistar rats orally for 16 weeks observed a significant decrease in ALT activity in both the blood and the liver, but no effect was on AST activity.…”
Section: Discussioncontrasting
confidence: 99%
“…Lee et al [ 26 ] stressed that copper nanoparticles, having a much larger specific surface area than macro- or microparticles, can cause completely different biological reactions. Mohammadyari et al [ 45 ] administered CuO nanoparticles (50 nm) to Wistar rats by intraperitoneal injection at dosages of 0, 100, 200 or 400 ppm for 15 d and observed a significant increase in serum AST, ALT and ALP activity only in the rats from the 400 ppm CuO-nano treatment as compared to 0 ppm. In a study in which rat diets were supplemented with CuNPs or CuMPs at doses of 100, 200 or 400 mg Cu/kg BW per d, AST, ALT, ALP and LDH activity increased with the dose of Cu [ 29 ].…”
Section: Discussionmentioning
confidence: 99%
“…According to our results reported in Table 1 , we observed a significant elevation in ALT and AST enzyme activity and TB level, the efficient indicators for liver damage, in group II. In the liver injury, the transport function of hepatocytes is disturbed, resulting in leakage of plasma membrane and elevation of the serum level of liver enzymes [ 28 , 29 ]. The increased TB concentration might be attributed to the failure of normal uptake, conjugation and excretion by the damaged hepatic parenchyma [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…Many reports verify substantial toxicity of CuO NPs, induced damages in nephrotic and hepatic tissues of rats that affect physiology and biochemical functioning of kidney and liver [11]. Mohammadyari et al [99] found rise in ALT and ALP upon treatment of CuO NPs demonstrating disturbance in liver's membrane that lead to cellular release of these enzymes. Lee et al [100] observed dose‐dependent increase in AST, ALP, ALT, TBIL, CRE, BUN and LDH while the level of TP (total protein) and TG (triglyceride) decreased significantly.…”
Section: Biochemical Alterations Induced By Cuo Npsmentioning
confidence: 99%